The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,810.00
Bid: 1,700.00
Ask: 1,813.00
Change: 0.00 (0.00%)
Spread: 113.00 (6.647%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets in the red with BoE, Fed in focus

Wed, 20th Nov 2013 11:33

- BoE voted unanimously on policy at last meeting- MPC attempts to play down rate-hike fears- Taper in focus ahead of FOMC minutestechMARK 2,627.20 -0.64%FTSE 100 6,670.70 -0.41%FTSE 250 15,181.39 -0.55%UK markets were trading in the red on Wednesday after the Bank of England expressed concerns with the economic recovery and as investors awaited the minutes of the latest Federal Reserve policy meeting. A number of heavyweight stocks were providing a drag on London's FTSE 100 index by midday after going ex-dividend, meaning that from today investors won't be able to get their hands on the companies' latest payouts.It was revealed this morning that the Bank of England's Monetary Policy Committee (MPC) voted unanimously to maintain the Bank Rate at 0.5% and the stock of asset purchases at £375bn at its latest meeting, as expected. However, the MPC attempted to ease fears over a sooner-than-expected tightening in monetary policy as the minutes of the meeting expressed "uncertainties over the durability of the recovery". The central bank reiterated that rates would be kept low until the unemployment rate reaches the 7% threshold, at which point policymakers would then reassess its stance.Analyst Philip Shaw from Investec said that the minutes didn't provide any firm clues to the timing of a possible rate increase. "Rather they conveyed the degree of uncertainty on the committee on the economic outlook and the recovery in productivity, which will be key factors in the monetary policy debate," he said.Meanwhile, the Federal Open Market Committee (FOMC) will release details of its October meeting later this evening as markets wait to hear about the central bank's decision to maintain its stimulus programme last month.However, comments from Fed Chairman Ben Bernanke last night were in focus this morning after he reiterated that any tapering of asset purchases remains dependent on incoming economic data, as he held back from shedding any light on the timetable for an impending withdrawal.Telecom Plus soars after H1 results, acquisitionsUtilities reseller Telecom Plus was a high riser this morning after agreeing to pay £218m to buy back two gas and electricity supply businesses from Npower which it sold in 2006. The announcement came as the firm delivered a 17% increase in revenues in the first half, as profits rose 10.1%.Ex-div stocks were weighing on the FTSE 100 with Vodafone, Tate & Lyle, Next, Carnival and Sainsbury among the stocks trading without the right to their latest payouts.Drinks group Diageo was under the weather after Chief Executive Ivan Menezes was reported as saying that the "uncertain" macro environment will continue to limit sales growth. Sector peer SABMiller was also out of favour this morning.Airline group easyJet was extending gains made yesterday after the company delivered a 51% increase in annual profits and unveiled an unexpected special dividend to shareholders.GlaxoSmithKline rose after completing the partial sale of Aspen Pharmacare, raising gross proceeds of 7.06bn South African rand ($695m).Engineering and construction firm Kentz was higher after being awarded a $190m contract with Qatar Petroleum for services on 775 wells across the Dukhan Oilfield in Qatar, extending the firms' long-standing relationship which started back in 1997.Fund manager Aberdeen rose after analysts at Bank of America Merrill Lynch upgraded their rating on the stock from 'underperform' to 'neutral'. FTSE 100 - RisersAberdeen Asset Management (ADN) 484.90p +2.04%British Sky Broadcasting Group (BSY) 838.50p +1.64%Travis Perkins (TPK) 1,752.00p +1.57%easyJet (EZJ) 1,362.00p +1.26%Pearson (PSON) 1,342.00p +0.98%Johnson Matthey (JMAT) 3,116.00p +0.84%Aviva (AV.) 429.90p +0.68%Rio Tinto (RIO) 3,277.50p +0.57%William Hill (WMH) 363.10p +0.50%Royal Dutch Shell 'B' (RDSB) 2,200.00p +0.46%FTSE 100 - FallersRexam (REX) 488.50p -2.98%Vodafone Group (VOD) 227.15p -2.11%Amec (AMEC) 1,160.00p -2.03%Hammerson (HMSO) 505.00p -1.94%Persimmon (PSN) 1,163.00p -1.86%Melrose Industries (MRO) 298.20p -1.84%Tate & Lyle (TATE) 806.50p -1.77%Bunzl (BNZL) 1,368.00p -1.72%Sainsbury (J) (SBRY) 404.80p -1.68%Vedanta Resources (VED) 955.00p -1.65%FTSE 250 - RisersTelecom Plus (TEP) 1,745.00p +15.79%International Personal Finance (IPF) 591.50p +2.69%Kentz Corporation Ltd. (KENZ) 555.50p +2.49%Lancashire Holdings Limited (LRE) 811.50p +2.40%BH Global Ltd. USD Shares (BHGU) 11.91 +1.79%Rathbone Brothers (RAT) 1,559.00p +1.56%BH Macro Ltd. EUR Shares (BHME) € 20.00 +1.52%NMC Health (NMC) 375.50p +1.49%BH Macro Ltd. USD Shares (BHMU) 19.69 +1.44%BTG (BTG) 446.30p +1.39%FTSE 250 - FallersTalkTalk Telecom Group (TALK) 266.20p -3.55%Centamin (DI) (CEY) 48.19p -3.43%Spirent Communications (SPT) 102.20p -3.31%Bovis Homes Group (BVS) 744.50p -2.93%African Barrick Gold (ABG) 186.40p -2.76%ITE Group (ITE) 304.10p -2.69%Kenmare Resources (KMR) 20.49p -2.66%Wood Group (John) (WG.) 788.50p -2.41%Ashmore Group (ASHM) 378.70p -2.40%Hiscox Ltd (HSX) 662.00p -2.36%BC
More News
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.